Geode Capital Management
ALXA

Geode Capital Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Geode Capital Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-91,033
Closed -$44 – 4107
2016
Q1 		$44 Sell
91,033
-24
-0% -$11 ﹤0.01% 3983
2015
Q4 		$63K Buy
91,057
+48
+0.1% +$50 ﹤0.01% 3970
2015
Q3 		$115K Buy
91,009
+48
+0.1% +$56 ﹤0.01% 3862
2015
Q2 		$99K Buy
90,961
+24
+0% +$36 ﹤0.01% 3773
2015
Q1 		$188K Buy
90,937
+72
+0.1% +$148 ﹤0.01% 3606
2014
Q4 		$135K Buy
90,865
+32,241
+55% +$57.5K ﹤0.01% 3715
2014
Q3 		$136K Buy
58,624
+2,136
+4% +$8.15K ﹤0.01% 3682
2014
Q2 		$258K Buy
56,488
+4,040
+8% +$17.4K ﹤0.01% 3429
2014
Q1 		$232K Buy
52,448
+72
+0.1% +$369 ﹤0.01% 3453
2013
Q4 		$247K Buy
52,376
+48
+0.1% +$236 ﹤0.01% 3364
2013
Q3 		$268K Buy
52,328
+48
+0.1% +$226 ﹤0.01% 3201
2013
Q2 		$227K Buy
+52,280
New +$237K ﹤0.01% 3187

Geode Capital Management's ALXA Position: Q2 2016 in Review

Geode Capital Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 91,033 shares — an estimated $44 sold.

Geode Capital Management first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $268K in Q3 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Geode Capital Management reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Geode Capital Management sold 91,033 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $44.
  • Geode Capital Management first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Geode Capital Management's Alexza Pharmaceuticals Inc position peaked at $268K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.